Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 567,500 shares, a decline of 44.9% from the April 30th total of 1,030,000 shares. Based on an average daily volume of 927,300 shares, […]